Analysis of adverse reactions of hesperidin sodium in Chongqing from 2014 to 2019
返回论文页
|更新时间:2022-11-04
|
Analysis of adverse reactions of hesperidin sodium in Chongqing from 2014 to 2019
Health Medicine Research and PracticeVol. 19, Issue 3, Pages: 31-36(2022)
作者机构:
1. 广东医科大学附属第二医院药学部
2. 广东医科大学附属第二医院肝胆胰外科
3. 重庆市药品不良反应监测中心药品不良反应监测科
4. 重庆市第九人民医院科教科
作者简介:
基金信息:
DOI:
CLC:R285.6
Published:2022,
扫 描 看 全 文
Guan Songmei, Ye Zhirong, Deng Li, et al. Analysis of adverse reactions of hesperidin sodium in Chongqing from 2014 to 2019. [J]. Health Medicine Research and Practice 19(3):31-36(2022)
DOI:
Guan Songmei, Ye Zhirong, Deng Li, et al. Analysis of adverse reactions of hesperidin sodium in Chongqing from 2014 to 2019. [J]. Health Medicine Research and Practice 19(3):31-36(2022)DOI:
Analysis of adverse reactions of hesperidin sodium in Chongqing from 2014 to 2019
Objective To investigate the epidemiological characteristics of adverse drug reactions(ADRs) with hesperidin sodium for injection and the factors associated with the occurrence of ADRs. Methods The ADR re-ports of hesperidin sodium for injection in Chongqing from 2014 to 2019 were selected for investigation. Epidemi-ological statistics of 1 391 ADR cases qualified for reporting were collected
and the ADR characteristics of 1 338 ADR reports eligible for inclusion were analyzed using the decision tree method and the association rule method. Results The ADR of hesperidin sodium was correlated with patients’ gender
age
route of administration
and reason for medication. The occurrence of ADRs was mainly concentrated in the 2 periods of 10-30 min and 1-3 d after medication administration. Conclusion The ADR of hesperidin sodium is relatively common in clinical practice
and the causes and characteristics of ADR should be fully understood to ensure the safe and effective clinical use of the drug.
关键词
注射用七叶皂苷钠药品不良反应(ADR)决策树关联规则
Keywords
Hesperidin sodium for injectionAdverse drug reaction(ADR)Decision treeAssociation rule